...
首页> 外文期刊>International Journal of Clinical and Experimental Pathology >MicroRNA-130a inhibits cell proliferation, invasion and migration in human breast cancer by targeting the RAB5A
【24h】

MicroRNA-130a inhibits cell proliferation, invasion and migration in human breast cancer by targeting the RAB5A

机译:MicroRNA-130a通过靶向RAB5A抑制人乳腺癌中的细胞增殖,侵袭和迁移

获取原文
   

获取外文期刊封面封底 >>

       

摘要

MiR-130a has been demonstrated to play important roles in many types of cancers. Nevertheless, its biological function in breast cancer remains largely unknown. In this study, we found that the expression level of miR-130a was down-regulated in breast cancer tissues and cells. Overexpression of miR-130a was able to inhibit cell proliferation, invasion and migration in MCF7 and MDA-MB-435 cells. With the bioinformatics analysis, we further identified that RAB5A was a directly target of miR-130a, and its mRNA and protein level was negatively regulated by miR-130a. Immunohistochemistry verified RAB5A was upregulated in breast cancer tissues. Therefore, the data reported here demonstrate that miR-130a is an important tumor suppressor in breast cancer, and imply that miR-130a/RAB5A axis have potential as therapeutic targets for breast cancer.
机译:已证明MiR-130a在许多类型的癌症中起重要作用。然而,其在乳腺癌中的生物学功能仍然未知。在这项研究中,我们发现miR-130a的表达水平在乳腺癌组织和细胞中被下调。 miR-130a的过表达能够抑制MCF7和MDA-MB-435细胞的增殖,侵袭和迁移。通过生物信息学分析,我们进一步确定RAB5A是miR-130a的直接靶标,而其mRNA和蛋白水平受miR-130a负调控。免疫组织化学证实,RAB5A在乳腺癌组织中上调。因此,此处报道的数据证明miR-130a是乳腺癌中重要的肿瘤抑制因子,并且暗示miR-130a / RAB5A轴具有作为乳腺癌治疗靶标的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号